Alkermes Inc. plc (ALKS)

NASDAQ

$43.79

$-0.35

(-0.79%)

Regular Market

Alkermes Inc. plc (ALKS) Live Price Chart

Last updated: ⁦2026-10-21 16:54:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Alkermes Inc. plc (ALKS) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $43.79, with a market capitalization of $7.21B and a P/E ratio of 111.91. Over the past 52 weeks, its price has ranged from $27.00 to $55.67. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$7.21B
Open	$44.12
Day's High	$80.71
Day's Low	$5.55
Previous Close	$44.11
Volume	796.60K
Average Volume	1.93M
P/E Ratio	111.91
52-Week High	$55.67
52-Week Low	$27.00
Dividend Yield	--
Earnings Date	--

Alkermes Inc. plc (ALKS) Stock Price Today

Alkermes Inc. plc (ALKS) is currently trading at $43.79 as of 2026-10-21 16:53:00, down 0.72% ($0.32) from the previous close of $44.11

During today's regular trading session, ALKS has traded between $5.55 and $80.71, with a trading volume of 796.60K shares. The current price is near the middle of today's range.

Alkermes Inc. plc (ALKS) 7-Day Stock Price Change

Over the past seven days, Alkermes Inc. plc (ALKS) moved from $40.26 to $43.79, representing a gain of 8.77% ($3.53).

The stock traded between $38.98 and $45.20 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 2.18 million shares, down versus the previous seven-day period, indicating lower trading activity.

ALKS 52-Week Price Position

Position in Range: 58.6%

52W Low$27.00

52W High$55.67

ALKS is currently trading at $43.79, placing it 58.6% of the way from its 52-week low of $27.00 to its 52-week high of $55.67. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Alkermes Inc. plc (ALKS)?

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Alkermes Inc. plc Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	2050
Exchange	NASDAQ
Company Website	https://www.alkermes.com

How to Buy Alkermes Inc. plc (ALKS) Stock on MEXC

Eligible investors can buy real shares of Alkermes Inc. plc (ALKS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ALKS and Place Your Order

Open the RealStocks trading page and search for ALKS. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Alkermes Inc. plc (ALKS) stock price today?

Alkermes Inc. plc (ALKS) is currently trading at $ 43.79, down 0.72% ($0.32) from the previous close of $ 44.11. Intraday prices update in real time during regular trading hours.

2.Is ALKS stock going up or down today?

As of 2026-10-21 16:53:00, ALKS is trading at $ 43.79, down 0.72% ($0.32) from its previous close of $ 44.11. The stock has traded between $ 5.55 and $ 80.71 during today’s regular session. Past price movements do not guarantee future results.

3.What is ALKS pre-market price?

As of 2026-10-21 16:53:00, ALKS is trading at $ 44.25 in pre-market trading, up 0.32% ($0.14) from the previous close of $ 44.11. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ALKS after-hours price?

As of 2026-10-21 16:53:00, ALKS is trading at $ 44.13 in after-hours trading, up 0.03% ($0.02) from the regular-session close of $ 44.11. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ALKS stock trading now?

ALKS trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ALKS sit relative to its 52-week high and low?

Over the past 52 weeks, ALKS has traded between a low of $ 27.00 and a high of $ 55.67. At $ 43.79, the stock is positioned 58.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Alkermes Inc. plc in?

Alkermes Inc. plc (ALKS) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Alkermes Inc. plc's market capitalization and where is it listed?

Alkermes Inc. plc is listed on the NASDAQ exchange with a market capitalization of $ 7.21B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ALKS valued in terms of P/E ratio and EPS?

ALKS trades at a P/E ratio of 111.91, based on trailing-twelve-month EPS of $ 0.39. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Alkermes Inc. plc pay a dividend?

Alkermes Inc. plc pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.